日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

High long-term retention rates of Secukinumab in psoriatic arthritis and ankylosing spondylitis: a 3-year interim analysis from the observational, prospective SERENA study, in Greek patients

在银屑病关节炎和强直性脊柱炎患者中,司库奇尤单抗的长期维持率较高:一项来自观察性前瞻性SERENA研究的3年中期分析(希腊患者)。

Bounas, Andreas; Kandyli, Anna; Katsifi, Gkikas; Boumpa, Dimitrios; Tektonidou, Maria G; Gazi, Sousana; Kotrotsios, Anastasios; Sakkas, Lazaros I; Georgiadis, Athanasios N; Settas, Loukas; Madia, Xenia; Ignatiadi, Dimitra; Sfikakis, Petros P

A Real-Life 208 Week Single-Centred, Register-Based Retrospective Study Assessing Secukinumab Survival and Long-Term Efficacy and Safety Among Greek Patients with Moderate to Severe Plaque Psoriasis, Including Difficult-to-Treat Manifestations Such as Genitals and Scalp

一项基于真实世界数据、单中心、注册登记的回顾性研究,历时 208 周,旨在评估司库奇尤单抗治疗希腊中重度斑块状银屑病(包括生殖器和头皮等难治性表现)患者的生存率、长期疗效和安全性。

Kyrmanidou, Eirini; Kemanetzi, Christina; Stavros, Chatzopoulos; Trakatelli, Myrto-Georgia; Patsatsi, Aikaterini; Madia, Xenia; Ignatiadi, Dimitra; Kalloniati, Evangelia; Apalla, Zoe; Lazaridou, Elizabeth